Royal Bank of Canada’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-11,420
| Closed | -$107K | – | 7499 |
|
|
2020
Q3 | $107K | Sell |
11,420
-1,438
| -11% | -$13.7K | ﹤0.01% | 4939 |
|
|
2020
Q2 | $98K | Sell |
12,858
-14,029
| -52% | -$107K | ﹤0.01% | 4856 |
|
|
2020
Q1 | $166K | Buy |
26,887
+5,318
| +25% | +$46.9K | ﹤0.01% | 4453 |
|
|
2019
Q4 | $262K | Buy |
21,569
+2,566
| +14% | +$28K | ﹤0.01% | 4449 |
|
|
2019
Q3 | $219K | Hold |
19,003
| – | – | ﹤0.01% | 4397 |
|
|
2019
Q2 | $190K | Sell |
19,003
-2,192
| -10% | -$23.6K | ﹤0.01% | 4513 |
|
|
2019
Q1 | $273K | Buy |
21,195
+2,124
| +11% | +$31.6K | ﹤0.01% | 4154 |
|
|
2018
Q4 | $290K | Sell |
19,071
-1,029
| -5% | -$19.6K | ﹤0.01% | 4107 |
|
|
2018
Q3 | $403K | Buy |
20,100
+748
| +4% | +$17K | ﹤0.01% | 4041 |
|
|
2018
Q2 | $378K | Buy |
19,352
+322
| +2% | +$7.12K | ﹤0.01% | 4009 |
|
|
2018
Q1 | $384K | Sell |
19,030
-432
| -2% | -$7.31K | ﹤0.01% | 3889 |
|
|
2017
Q4 | $258K | Sell |
19,462
-16,127
| -45% | -$243K | ﹤0.01% | 4267 |
|
|
2017
Q3 | $656K | Sell |
35,589
-2,135
| -6% | -$39.8K | ﹤0.01% | 3584 |
|
|
2017
Q2 | $694K | Sell |
37,724
-131,245
| -78% | -$2.6M | ﹤0.01% | 3401 |
|
|
2017
Q1 | $3.81M | Sell |
168,969
-4,198
| -2% | -$101K | ﹤0.01% | 2104 |
|
|
2016
Q4 | $6.03M | Buy |
173,167
+14,233
| +9% | +$425K | ﹤0.01% | 1832 |
|
|
2016
Q3 | $3.9M | Sell |
158,934
-461,519
| -74% | -$11.5M | ﹤0.01% | 2078 |
|
|
2016
Q2 | $14.8M | Buy |
620,453
+445,910
| +255% | +$10.2M | 0.01% | 1153 |
|
|
2016
Q1 | $4.08M | Buy |
174,543
+55,940
| +47% | +$1.33M | ﹤0.01% | 1945 |
|
|
2015
Q4 | $3.58M | Buy |
118,603
+21,938
| +23% | +$709K | ﹤0.01% | 2083 |
|
|
2015
Q3 | $3.84M | Buy |
96,665
+14,178
| +17% | +$880K | ﹤0.01% | 1748 |
|
|
2015
Q2 | $5.7M | Buy |
82,487
+5,221
| +7% | +$328K | ﹤0.01% | 1526 |
|
|
2015
Q1 | $4.22M | Sell |
77,266
-27,600
| -26% | -$1.32M | ﹤0.01% | 1712 |
|
|
2014
Q4 | $4.47M | Buy |
104,866
+16,200
| +18% | +$585K | ﹤0.01% | 1735 |
|
|
2014
Q3 | $2.83M | Sell |
88,666
-72,255
| -45% | -$1.54M | ﹤0.01% | 2032 |
|
|
2014
Q2 | $3.33M | Hold |
160,921
| – | – | ﹤0.01% | 1928 |
|
|
2014
Q1 | $3.11M | Buy |
+160,921
| New | +$3.42M | ﹤0.01% | 1930 |
|
|
2013
Q4 | – | Sell |
-563
| Closed | -$12K | – | 6247 |
|
|
2013
Q3 | $12K | Buy |
+563
| New | +$13.3K | ﹤0.01% | 5348 |
|
Royal Bank of Canada's AMAG Position: Q4 2020 in Review
Royal Bank of Canada sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 11,420 shares — an estimated $107K sold.
Royal Bank of Canada first reported a position in AMAG in Q3 2013 and held it in 28 quarters. The position peaked at $14.8M in Q2 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Royal Bank of Canada reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Royal Bank of Canada sold 11,420 AMAG Pharmaceuticals shares in Q4 2020, an estimated $107K.
- Royal Bank of Canada first reported a position in AMAG Pharmaceuticals in Q3 2013 and held it in 28 quarters.
- Royal Bank of Canada's AMAG Pharmaceuticals position peaked at $14.8M in Q2 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.